Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Sep;53(3):573-80.

Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies

Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies

T A Poulton et al. Clin Exp Immunol. 1983 Sep.

Abstract

Immune complexes from patients with ovarian and endometrial cancer have been examined using the C1q solid phase (C1qSP) and polyethylene glycol (PEG) precipitation assays. The amount of IgG in the PEG precipitates was inversely correlated with the amount of IgM whilst the IgM values correlated positively with the C1qSP assay values. Separation studies revealed that most of the C1qSP activity was not precipitated from cancer sera by 2% PEG. The immune complexes were fractionated on Sephacryl S-300. Both the PEG precipitation and C1qSP assays detected high molecular weight immune complex like activity (greater than 19S). The C1qSP assay also detected a second peak of activity at approximately 7-8S. Most of the PEG detectable immune complexes from sera dissociated during column chromatography, whereas the C1qSP detectable complexes were relatively stable. Furthermore the IgG from fractionated PEG precipitates emerged as a monomer (7S) component. The PEG assay appeared to be detecting a high molecular weight complex containing mostly IgG rather than IgM with a low affinity for C1q, which was easily dissociated. The C1qSP assay detected a more stable high molecular weight complex containing a relatively high proportion of IgM and a low molecular weight complex, both with a high affinity for C1q.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1976 Jan;57(1):169-82 - PubMed
    1. Int J Cancer. 1976 Sep 15;18(3):310-6 - PubMed
    1. Int J Cancer. 1977 Jan;19(1):12-7 - PubMed
    1. J Clin Invest. 1977 Jun;59(6):1134-42 - PubMed
    1. J Immunol. 1977 Aug;119(2):657-63 - PubMed

LinkOut - more resources